Hipersensibilidad a Betalactámicos. Dra Yurlany Gutiérrez (20 de septiembre 2018)

De


Hipersensibilidad a Betalactámicos.  Dra Yurlany Gutiérrez (20 de septiembre 2018)

Comentarios

  1. Ricardo Cardona Villa21 de septiembre de 2018 a las 9:39

    Artículo recomendado:

    Cross-reactivity in b-Lactam Allergy
    Robert J. Zagursky, PhD, and Michael E. Pichichero, MD Rochester, NY

    b-Lactam drugs (penicillins, amoxicillin, and cephalosporins)
    account for 42.6% of all severe drug-induced anaphylaxis. In this
    review, we focus on clinically significant immunologic crossreactivity
    in patients with confirmed penicillin allergy to
    cephalosporins, and the structural involvement of the R1 and R2
    chemical side chains of the cephalosporins causing IgE-mediated
    cross-reactivity with penicillin and other cephalosporins. Skin
    tests predict IgE-mediated reactions and showed cross-reactivity
    between penicillins and early generation cephalosporins that
    shared side chains, but confirmatory challenge data are lacking.
    Later-generation cephalosporins, which have distinct side chains,
    do not have any skin test cross-reactivity with penicillin/
    amoxicillin. There is debate as to the involvement of R2 side
    chains as the antigenic determinants that cause IgE-mediated
    hypersensitivity with various cephalosporins. Avoidance of
    cephalosporins, when they are the drug of choice in a penicillinallergic individual, results in significant morbidity that outweighs the low risk of anaphylaxis. We conclude that there is ample evidence to allow the safe use of cephalosporins in patients with isolated confirmed penicillin or amoxicillinallergy.

    Texto completo:
    http://dx.doi.org/10.1016/j.jaip.2017.08.027

    ResponderEliminar

Publicar un comentario

Entradas populares de este blog

Adaptive immunity to SARS-CoV-2 and COVID-19 Alessandro

De
Adaptive immunity to SARS-CoV-2 and COVID-19 Authors:  Alessandro Sette and Shane Crotty Abstract: The adaptive immune system is important for control of most viral infections. The three fundamental compo- nents of the adaptive immune system are B cells (the source of antibodies), CD4+ T cells, and CD8+ T cells. The armamentarium of B cells, CD4+ T cells, and CD8+ T cells has differing roles in different viral infections and in vaccines, and thus it is critical to directly study adaptive immunity to SARS-CoV-2 to understand COVID-19. Knowledge is now available on relationships between antigen-specific immune responses and SARS-CoV-2 infection. Although more studies are needed, a picture has begun to emerge that reveals that CD4+ T cells, CD8+ T cells, and neutralizing antibodies all contribute to control of SARS-CoV-2 in both non-hospitalized and hospitalized cases of COVID-19. The specific functions and kinetics of these adaptive immune responses are discussed, as well as their in...
Leer más

The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria

De
The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria Authors: T. Zuberbier, A.H. Abdul Latiff, M. Abuzakouk, S. Aquilina, R. Asero, D. Baker, B. Ballmer-Weber, C. Bangert, M. Ben-Shoshan, J.A. Bernstein, C. Bindslev-Jensen, K. Brockow, Z. Brzoza, H.J. Chong Neto, M. Church, P.R. Criado, I.V. Danilycheva, C. Dressler, L.F. Ensina, L. Fonacier, M. Gaskins, K. Gáspár, A. Gelincik, A. Giménez-Arnau, K. Godse, M. Gonçalo, C. Grattan, M. Grosber, E. Hamelmann, J. Hébert, M. Hide, A. Kaplan, A. Kapp, A. Kessel, E. Kocatürk, K. Kulthanan, D. Larenas-Linnemann, A. Lauerma, T. Leslie, M. Magerl, M. Makris, R.Y. Meshkova, M. Metz, D. Micallef, C.G. Mortz, A. Nast, H. Oude-Elberink, R. Pawankar, P. Pigatto, H. Ratti Sisa, M.I. Rojo Gutiérrez, S.S. Saini, P. Schmid-Grendelmeier, B. Sekerel, F. Siebenhaar, H. Siiskonen, A. Soria, P. Staubach-Renz, L. Stingeni, G. Sussman, A. Szegedi, S.F. Thomsen, Z. Vadas, C. Vesterga...
Leer más

La biopsia cutánea en la urticaria crónica: cuándo realizarla, qué buscar y dónde hacerlo

De
La biopsia cutánea en la urticaria crónica: cuándo realizarla, qué buscar y dónde hacerlo Autores: A. López Mateos, M.J. Sánchez Pujol y J.F. Silvestre Salvador Resumen: La urticaria crónica es una entidad relativamente frecuente en la práctica clínica habitual, cuyo diagnóstico se establece de forma clínica. Sin embargo, existen ocasiones en las que está indicada la realización de una biopsia cutánea para confirmar el diagnóstico y diferenciarla de otras patologías que pueden cursar con erupciones urticariformes. En este trabajo revisamos los hallazgos histopatológicos que podemos encontrar tanto en la urticaria crónica como en las patologías que plantean un diagnóstico diferencial. Con base en ello, proponemos un algoritmo que recoge las indicaciones para realizar una biopsia cutánea y la orientación del diagnóstico en función de los hallazgos histopatológicos que encontremos en la misma. DOI:   https://doi.org/10.1016/j.ad.2020.11.016
Leer más